Related Experiment Video
Updated: Nov 4, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
COVID-19 and cardiovascular complications - preliminary results of the LATE-COVID study
Joanna Lewek1,2, Izabela Jatczak-Pawlik1,3, Marek Maciejewski2
1Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.
Insights
Post-COVID-19 cardiovascular complications can be severe, particularly in patients with diabetes. Key indicators of severity include reduced ejection fraction and elevated C-reactive protein and troponin levels.
Area of Science:
- Cardiology
- Infectious Diseases
- Internal Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is known to affect multiple organs, leading to various complications.
- Cardiovascular issues are among the significant post-COVID-19 complications observed in patients.
Purpose of the Study:
- To investigate the clinical characteristics and outcomes of cardiovascular complications following COVID-19.
- To identify factors associated with the severity of these post-COVID-19 cardiovascular issues.
Main Methods:
- Analysis of 51 patients admitted for potential cardiovascular complications post-COVID-19.
- Data collection included clinical information, laboratory tests, echocardiography, and 24-hour ECG monitoring.
Main Results:
- Severe cardiovascular complications occurred in 27.5% of hospitalized patients, typically 1-4 months after recovery.
- Patients with severe complications showed higher rates of diabetes, decreased ejection fraction, elevated heart rate, C-reactive protein, and troponin T.
- Dyspnea and exercise intolerance were more prevalent in those with severe complications.
Conclusions:
- Diabetes, elevated C-reactive protein (CRP), troponin levels, and reduced left ventricular ejection fraction are linked to severe cardiovascular complications after COVID-19.
- Heart rate variability parameters also correlate with the severity of post-COVID-19 cardiovascular sequelae.
Introduction:
Coronavirus disease 2019 (COVID-19) may affect many organs and may be responsible for numerous complications including cardiovascular problems.
Methods:
We analysed consecutive patients (n = 51) admitted to the cardiology department between 1st October 2020 and 31st January 2021 due to symptoms which might have reflected cardiovascular complications following COVID-19. We collected data concerning clinical characteristics, results of laboratory tests, echocardiography and 24-hour ambulatory ECG recording.
Results:
The post-COVID-19 complications appeared 1-4 months after disease recovery. Severe cardiovascular complications were observed in 27.5% of hospitalized patients. In comparison to those with mild complications, patients with severe complications had significantly higher prevalence of diabetes (36 vs. 8%; p = 0.01), decrease in ejection fraction (36% vs. 0%, p < 0.001), higher resting heart rate at admission (85 vs. 72 bpm; p < 0.001), and higher levels of C-reactive protein (p = 0.02) and troponin T (17.9 vs. 4.2 pg/ml; p = 0.01). Dyspnoea and exercise intolerance were also more frequent in patients with severe complications.
Conclusions:
Diabetes, elevated level of CRP and troponin, heart rate variability parameters and worsening of left ventricular ejection fraction are related to the severity of cardiovascular complications following COVID-19 infection.
More Related Videos
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations